Support the Emily Whitehead Foundation

Emily’s dad, Tom Whitehead, shared their family’s story with us at our GCSG 2020 Virtual Conference and what an inspiring story of strength and resilience that story is.  At age five, Emily Whitehead was diagnosed with an aggressive form of acute lymphoblastic leukemia (ALL) that failed to respond to chemotherapy. As a last hope, Emily was enrolled in a clinical trial at Children’s Hospital of Philadelphia (CHOP) and became the first pediatric patient in the world to receive CAR-T cell therapy and have her immune system trained to fight cancer. The experimental therapy worked and Emily is now healthy and 8 years cancer free.

 

The Emily Whitehead Foundation is a non-profit organization committed to activating the cure for childhood cancer. The foundation directly funds CAR-T cell therapy research, raises awareness through education and sharing inspiring stories, and is a resource for families affected by childhood cancer to find alternative treatments. For more information, please visit www.EmilyWhiteheadFoundation.org.

Related Articles.

All Articles

COVID-19

GCSG 2018-2019 Scholarship

A Journey of Growth and Discovery: My Experience at Cranfield and the GCSG European Knowledge Forum

Become a member

Global Clinical Supplies Group

Join GCSG for full access...

to our educational resources, conference materials and our directory of more than 480 Clinical Supply colleagues. Experience the culture of collaboration, It only takes approximately 3 minutes 22 seconds.

Please note that membership is included and FREE of charge when you sign up for an event.